Automatic analyzer for guanase activity
    1.
    发明授权
    Automatic analyzer for guanase activity 失效
    自动分析仪进行鸟类活动

    公开(公告)号:US4788141A

    公开(公告)日:1988-11-29

    申请号:US078009

    申请日:1987-07-24

    CPC分类号: C12Q1/34 G01N2333/978

    摘要: An automatic analyzer comprising a plurality of sample containers for accommodating different blood samples individually, specific sample container moving means, a plurality of reagent containers for accommodating at least a reagent for an assay of guanase activity, a specific reagent container holding means, a plurality of reaction containers, specific reaction container moving means, specific sample pouring means, specific cleaning vessels, specific stirring means, specific measuring means, specific cleaning means, a specific analog-digital converter, specific counting-calculating means, a specific display means, and specific operation control means, so that the display means produces a signal for excluding the measured blood sample corresponding to a display value when the display value is above a predetermined reference value of guanase activity.

    摘要翻译: 一种自动分析装置,其特征在于,包括分别容纳不同的血液样本的多个检体容器,特定的检体容器移动机构,至少容纳用于检测动物活动的试剂的多个试剂容器,特定试剂容器保持机构, 反应容器,特定反应容器移动装置,特定的样品注入装置,特定的清洁容器,特定的搅拌装置,特定的测量装置,特定的清洁装置,特定的模拟数字转换器,特定的计数计算装置,特定的显示装置和特定的 操作控制装置,使得当显示值高于动画活动的预定参考值时,显示装置产生用于排除与显示值相对应的测量血样的信号。

    Rapid assaying method for guanase
    2.
    发明授权
    Rapid assaying method for guanase 失效
    guanase快速检测方法

    公开(公告)号:US4550076A

    公开(公告)日:1985-10-29

    申请号:US424182

    申请日:1982-09-27

    IPC分类号: C12Q1/26 C12Q1/28 C12Q1/34

    摘要: The guanase activity in body fluids such as blood serum can be rapidly and accurately assayed by (I) decomposing guanine with the guanase in the specimen to xanthine and ammonia at pH 7-9, preferably at pH 8, (II) decomposing the xanthine formed by former step I with xanthine oxidase to uric acid and hydrogen peroxide, (III) reacting the reactant solution of the former step II with 3-methyl-2-benzothiazolinonehydrazone, an aniline derivative such as N,N-di-lower-alkylaniline and peroxidase, and finally measuring the optical absorption of the reactant solution of the step III at 570-600 nm. The all steps can be completed within 15 minutes. Therefore, this assay is adoptable for automatic assay of guanase on usual clinically available automatic analyzers.

    摘要翻译: 通过(I)将样品中的鸟嘌呤分解为黄嘌呤和氨,pH7-9,优选pH8,(II)分解形成的黄嘌呤的鸟嘌呤,可快速准确地测定体液如血清中的鸟苷酸活性 通过前一步骤I将黄嘌呤氧化酶与尿酸和过氧化氢反应,(III)使前一步骤II的反应物溶液与3-甲基-2-苯并噻唑酮腙,苯胺衍生物如N,N-二低级烷基苯胺和 过氧化物酶,最后在570-600nm测量步骤III的反应物溶液的光吸收。 所有步骤可在15分钟内完成。 因此,该测定法可用于通常临床可用的自动分析仪上的鸟苷酸的自动测定。

    5-fluorouracil derivatives
    6.
    发明授权
    5-fluorouracil derivatives 失效
    5-氟尿嘧啶衍生物

    公开(公告)号:US5047521A

    公开(公告)日:1991-09-10

    申请号:US150407

    申请日:1988-02-09

    摘要: This invention relates to a novel 5-fluorouracil derivative represented by the formula ##STR1## wherein R.sup.y is a hydrogen atom or a specific acyl group, Z is a phenyl-lower alkoxy-lower alkyl group, thienyl-lower alkyl group optionally substituted with halogen atom on the thienyl ring, or a group ##STR2## wherein R.sup.1 and R.sup.2 are each a hydrogen atom, a specific acyl group, phenyl-lower alkyl group having a group R.sup.x OCO-- on the phenyl ring, or a group --(A).sub.n B, R.sup.x being a specific organic group, A being a lower alkylene group, n being 0 or 1, and B being a 5- or 6-membered unsaturated heterocyclic group having 1 to 4 hetero-atoms selected from N, O and S and optionally having a benzene ring, naphthalene ring or pyridine ring condensed therewith, with the proviso that R.sup.1 and R.sup.2 are not hydrogen atoms or specific acyl groups at the same time; to a process for preparing the same; and to an anticancer composition comprising the same as an effective ingredient.

    摘要翻译: PCT No.PCT / JP87 / 00275 Sec。 371日期1988年2月9日 102(e)1988年2月9日PCT PCT公开1987年4月30日PCT公布。 公开号WO87 / 06582 日本公开日:1987年11月5日。本发明涉及由式(1)表示的新型5-氟尿嘧啶衍生物,其中R y为氢原子或特定酰基,Z为苯基 - 低级烷氧基 - 低级烷基 任选被噻吩基环上的卤素原子取代的噻吩基 - 低级烷基,或其中R 1和R 2各自为氢原子,特定酰基,具有基团R xOCO-的苯基 - 低级烷基基团 环,或基团 - (A)nB,Rx是特定的有机基团,A是低级亚烷基,n是0或1,B是具有1〜4个杂原子的5或6元不饱和杂环基, 选自N,O和S且任选具有苯环的原子,萘环或与其缩合的吡啶环,条件是R1和R2不同时为氢原子或特定酰基; 一个制备它的过程; 以及包含其作为有效成分的抗癌组合物。